Medios AG

Medios is a leading specialty pharma company in Europe focused on wholesale of specialty pharmaceuticals and the compounding and supply of patient-specific therapies.

15.06%

Ownership

2024

Investment year

Registered office
Berlin, Germany
Business Sector
Healthcare

“Pan-European platform focusing on specialty pharmaceuticals.”

Investment thesis

Our investment thesis is built on several attractive attributes:

  • Margin increase and more resilience through regional diversification and a business-mix shift towards higher value-added services
  • A defensive, non-cyclical market benefitting from structural growth driven by an aging population alongside a shift towards more individualized and new therapies
  • Medios has strong market positions in its focus markets (e.g. Germany, Netherlands, Belgium)
  • Strong growth track record and significant M&A expansion potential in Europe
  • Ambition to capture further outsourced compounding volumes
close
close